These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31800144)

  • 1. Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease.
    Cressatti M; Juwara L; Galindez JM; Velly AM; Nkurunziza ES; Marier S; Canie O; Gornistky M; Schipper HM
    Mov Disord; 2020 Mar; 35(3):468-477. PubMed ID: 31800144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson's disease.
    Song W; Kothari V; Velly AM; Cressatti M; Liberman A; Gornitsky M; Schipper HM
    Mov Disord; 2018 Apr; 33(4):583-591. PubMed ID: 29488275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
    Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-221 serves as a biomarker for Parkinson's disease.
    Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
    Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial HMOX1 expression promotes central and peripheral α-synuclein dysregulation and pathogenicity in parkinsonian mice.
    Cressatti M; Song W; Turk AZ; Garabed LR; Benchaya JA; Galindez C; Liberman A; Schipper HM
    Glia; 2019 Sep; 67(9):1730-1744. PubMed ID: 31180611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
    PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
    He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
    Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease.
    De Bartolo MI; Vivacqua G; Belvisi D; Mancinelli R; Fabbrini A; Manzo N; Costanzo M; Leodori G; Conte A; Fabbrini G; Morini S; Berardelli A
    Ann Neurol; 2023 Mar; 93(3):446-459. PubMed ID: 36385395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In search of Parkinson's disease biomarkers - is the answer in our mouths? A systematic review of the literature on salivary biomarkers of Parkinson's disease.
    Figura M; Friedman A
    Neurol Neurochir Pol; 2020; 54(1):14-20. PubMed ID: 32003440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.
    Oosterveld LP; Verberk IMW; Majbour NK; El-Agnaf OM; Weinstein HC; Berendse HW; Teunissen CE; van de Berg WDJ
    Mov Disord; 2020 Feb; 35(2):288-295. PubMed ID: 31737952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines, miRNAs, and Antioxidants as Combined Non-invasive Biomarkers for Parkinson's Disease.
    Ghit A; Deeb HE
    J Mol Neurosci; 2022 May; 72(5):1133-1140. PubMed ID: 35199307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease.
    Ravanidis S; Bougea A; Papagiannakis N; Maniati M; Koros C; Simitsi AM; Bozi M; Pachi I; Stamelou M; Paraskevas GP; Kapaki E; Moraitou M; Michelakakis H; Stefanis L; Doxakis E
    Mov Disord; 2020 Mar; 35(3):457-467. PubMed ID: 31799764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA expression levels in Turkish patients with Parkinson's disease.
    Ozdilek B; Demircan B
    Int J Neurosci; 2021 Dec; 131(12):1181-1189. PubMed ID: 32546033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miR-153 and miR-223 Levels as Potential Biomarkers in Parkinson's Disease.
    Wu L; Xu Q; Zhou M; Chen Y; Jiang C; Jiang Y; Lin Y; He Q; Zhao L; Dong Y; Liu J; Chen W
    Front Neurosci; 2022; 16():865139. PubMed ID: 35655754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
    Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
    Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Cao XY; Lu JM; Zhao ZQ; Li MC; Lu T; An XS; Xue LJ
    Neurosci Lett; 2017 Mar; 644():94-99. PubMed ID: 28223160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
    Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
    Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
    Alvarez-Erviti L; Seow Y; Schapira AH; Rodriguez-Oroz MC; Obeso JA; Cooper JM
    Cell Death Dis; 2013 Mar; 4(3):e545. PubMed ID: 23492776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.